NAS:CYCCP.PFD (USA)  
Cyclacel Pharmaceuticals Inc logo

Cyclacel Pharmaceuticals Inc

(Preferred)
$ 7.10 0 (0%) 08:08 PM EST
P/E:
At Loss
P/B:
0.51
Market Cap:
$ -
Enterprise V:
$ -31.15M
Volume:
2.90K
Avg Vol (2M):
790.00
Also Trade In:
Volume:
2.90K
Market Cap $:
-
PE Ratio:
At Loss
Avg Vol (2-Month):
790.00
Enterprise Value $:
-31.15M
PB Ratio:
0.51
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom.
Name Current Vs Industry Vs History
Cash-To-Debt 257.32
Equity-to-Asset 0.86
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.35
9-Day RSI 59.74
14-Day RSI 58.01
6-1 Month Momentum % 4.07
12-1 Month Momentum % -12.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.38
Quick Ratio 6.38
Cash Ratio 5.79

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 2.42
Forward Dividend Yield % 9.68
5-Year Yield-on-Cost % 2.42
3-Year Average Share Buyback Ratio -151.9
Name Current Vs Industry Vs History
ROE % -51.67
ROA % -45.39
ROIC % -833.63
ROC (Joel Greenblatt) % -20061.29
ROCE % -66.99

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.51
EV-to-EBIT 0.47
EV-to-EBITDA 0.47
EV-to-FCF 0.61
Earnings Yield (Greenblatt) % 212.77

Financials (Next Earnings Date:2022-11-10 Est.)

CYCCP.PFD's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CYCCP.PFD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) 0
Beta -0.27
Volatility % 32.68
14-Day RSI 58.01
14-Day ATR ($) 0.157793
20-Day SMA ($) 6.908
12-1 Month Momentum % -12.98
52-Week Range ($) 5.17 - 8.75
Shares Outstanding (Mil) 0

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cyclacel Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Cyclacel Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.